New drug mechanisms

British Journal of Clinical Pharmacology

Volumn 68, Issue 4, 2009, Pages 480-481

  Dubois, Eline A ^a   Cohen, Adam F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 2; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY CONJUGATE; ANTIRHEUMATIC AGENT;

ANTIGEN PRESENTING CELL; DISEASE SEVERITY; DIZZINESS; DRUG INDICATION; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; INFECTION; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SHORT SURVEY; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; ARTICLE;

ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOCONJUGATES; METHOTREXATE;

EID: 70449090000     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03502.x     Document Type: Short Survey

References (2)

1. Available at http://www.emea.europa.eu/humandocs/Humans/EPAR/orencia/ orencia.htm
2. Moreland L, Bate G, Kirkpatrick P. Fresh from the pipeline: Abatacept. Nat Rev Drug Discov 2006; 5: 185-6.